Skip to main content
. 2021 May 20;12:680382. doi: 10.3389/fmicb.2021.680382

Table 3.

In vitro antifungal activity of ganetespib used alone or in combination with FLC against azole-resistant clinically isolated strains.

Strains MIC80
(μg/mL)
FICFLC
(μg/mL)
FICcompd
(μg/mL)
FICI
C. tropicalis 5008 >64 0.5 2 0.039
C. albicans 7781 >64 0.25 2 0.035
C. auris 0029 >64 32 64 1.500
C. glabrata 9703 >64 16 8 1.125